SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-016086
Filing Date
2022-08-09
Accepted
2022-08-09 16:19:25
Documents
76
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q me-20220630.htm   iXBRL 10-Q 3000412
2 EX-31.1 me-ex31_1.htm EX-31.1 31379
3 EX-31.2 me-ex31_2.htm EX-31.2 29049
4 EX-32.1 me-ex32_1.htm EX-32.1 19876
5 EX-32.2 me-ex32_2.htm EX-32.2 19846
  Complete submission text file 0000950170-22-016086.txt   13344428

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT me-20220630_pre.xml EX-101.PRE 560183
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT me-20220630_lab.xml EX-101.LAB 710154
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT me-20220630_cal.xml EX-101.CAL 57166
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT me-20220630_def.xml EX-101.DEF 388767
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT me-20220630.xsd EX-101.SCH 92755
70 EXTRACTED XBRL INSTANCE DOCUMENT me-20220630_htm.xml XML 3032578
Mailing Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address 349 OYSTER POINT BOULEVARD SOUTH SAN FRANCISCO CA 94080 (650) 938-6300
23andMe Holding Co. (Filer) CIK: 0001804591 (see all company filings)

IRS No.: 871240344 | Fiscal Year End: 0331
Type: 10-Q | Act: 34 | File No.: 001-39587 | Film No.: 221148626
SIC: 2834 Pharmaceutical Preparations